Top 10 HIV prevention stories from CROI 2020
Supporting PrEP in eastern Europe and central Asia
HIV PrEP also prevents hepatitis B – and works better than the hepatitis B vaccine
Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP
Diagnostic challenges with PrEP use during early HIV infection
Unique transgender vulnerabilities require tailored and specific interventions
Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds
New PEP studies revive interest in post-exposure prevention
HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention
